These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 25250015)
1. O-GlcNAcylation and Metabolic Reprograming in Cancer. Jóźwiak P; Forma E; Bryś M; Krześlak A Front Endocrinol (Lausanne); 2014; 5():145. PubMed ID: 25250015 [TBL] [Abstract][Full Text] [Related]
2. Bitterness in sugar: O-GlcNAcylation aggravates pre-B acute lymphocytic leukemia through glycolysis via the PI3K/Akt/c-Myc pathway. Zhang B; Zhou P; Li X; Shi Q; Li D; Ju X Am J Cancer Res; 2017; 7(6):1337-1349. PubMed ID: 28670495 [TBL] [Abstract][Full Text] [Related]
3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967 [TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins. Dehennaut V; Leprince D; Lefebvre T Front Endocrinol (Lausanne); 2014; 5():155. PubMed ID: 25309514 [TBL] [Abstract][Full Text] [Related]
5. The potential role of O-GlcNAc modification in cancer epigenetics. Forma E; Jóźwiak P; Bryś M; Krześlak A Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978 [TBL] [Abstract][Full Text] [Related]
6. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356 [TBL] [Abstract][Full Text] [Related]
7. Feedback Regulation of Lin CH; Liao CC; Chen MY; Chou TY Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653 [TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547 [TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation: A New Cancer Hallmark? Fardini Y; Dehennaut V; Lefebvre T; Issad T Front Endocrinol (Lausanne); 2013; 4():99. PubMed ID: 23964270 [TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer. Parker MP; Peterson KR; Slawson C Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244 [TBL] [Abstract][Full Text] [Related]
15. Cross regulation between mTOR signaling and O-GlcNAcylation. Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020 [TBL] [Abstract][Full Text] [Related]
16. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells. Ma Z; Vocadlo DJ; Vosseller K J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772 [TBL] [Abstract][Full Text] [Related]
17. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation. Nagel AK; Ball LE Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147 [TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle. Hanover JA; Chen W; Bond MR J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839 [TBL] [Abstract][Full Text] [Related]